Glucagon, sold under the brand name Baqsimi among others, is a medication and hormone. As a medication it is used to treat low blood sugar, beta blocker...
26 KB (1,943 words) - 14:26, 28 July 2024
Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It raises the concentration of glucose and fatty acids in the bloodstream and is...
24 KB (2,821 words) - 06:18, 10 July 2024
for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered...
66 KB (5,434 words) - 17:03, 8 August 2024
The glucagon-like peptide-1 receptor (GLP1R) is a G protein-coupled receptor (GPCR) found on beta cells of the pancreas and on neurons of the brain. It...
33 KB (4,071 words) - 15:36, 30 July 2024
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon...
26 KB (3,386 words) - 20:19, 8 August 2024
PMC 4832440. PMID 26811245. "Obesity Medication: Gastrointestinal Agents, Other, CNS Stimulants, Anorexiants, Glucagon-like Peptide-1 Agonists, Antidepressants...
53 KB (4,991 words) - 05:08, 21 July 2024
nausea, diarrhea, vomiting, abdominal pain, and decreased appetite. It is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37)...
16 KB (1,511 words) - 23:59, 19 July 2024
who received 12.5 or 25 mg/d of the medication. Amylin agonist analogues slow gastric emptying and suppress glucagon. They have all the incretins actions...
50 KB (5,223 words) - 12:53, 31 July 2024
Hypoglycemia (section Medications)
1 diabetics, because medications that treat type 2 diabetes like metformin, glitazones, alpha-glucosidase inhibitors, glucagon-like peptide 1 agonists...
63 KB (6,112 words) - 14:44, 1 August 2024
GLP-1 receptor agonist (redirect from Glucagon-like peptide-1 analog)
Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of anorectic drugs that reduce...
37 KB (3,888 words) - 22:53, 31 July 2024
glucagon release. Exenatide was approved for medical use in the United States in 2005. In 2019, it was the 312th most commonly prescribed medication in...
24 KB (2,087 words) - 16:42, 11 May 2024
group of participants, compared to earlier phases.[citation needed] Glucagon (medication) Parker VE, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper...
6 KB (219 words) - 09:03, 29 December 2023
are unclear. It is given by injection under the skin. Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as...
31 KB (2,666 words) - 11:03, 12 June 2024
Ketoacidosis (section Medications)
dehydration can cause an increase in counterregulatory hormones such as glucagon, cortisol and growth hormone which may further increase free fatty acid...
12 KB (1,178 words) - 22:33, 14 March 2024
stimulate glucagon upon hypoglycemia prevents a glucagon-mediated rescue of glucose levels. Onset of type 1 diabetes is followed by an increase in glucagon secretion...
95 KB (10,828 words) - 11:19, 16 July 2024
treatment, and Zepbound for weight loss. Tirzepatide is a GIP receptor and glucagon-like peptide-1 agonist. The most common side effects include nausea, vomiting...
44 KB (3,480 words) - 15:49, 6 August 2024
increasing the production of insulin and decreasing the production of glucagon by the pancreas. Sitagliptin was developed by Merck & Co. and approved...
20 KB (1,575 words) - 06:24, 24 March 2024
disease. The hormone Glucagon-like Peptide 1 can lessen the brain's inflamed reaction caused by amyloid beta oxidative stress. Glucagon-like Peptide 1 can...
25 KB (2,525 words) - 01:56, 12 July 2024
mostly to regulate blood sugar levels, secreting the hormones insulin, glucagon, somatostatin and pancreatic polypeptide. As a part of the digestive system...
50 KB (5,610 words) - 14:40, 4 August 2024
Epinephrine, also known as adrenaline, is a medication and hormone. As a medication, it is used to treat several conditions, including anaphylaxis, cardiac...
42 KB (3,678 words) - 05:36, 10 August 2024
increasing the production of insulin and decreasing the production of glucagon by the pancreas. Linagliptin was approved for medical use in the United...
11 KB (607 words) - 05:27, 10 June 2024
– was approved by the FDA in 2006. Glucagon increases blood glucose levels, and DPP-4 inhibitors reduce glucagon and blood glucose levels. The mechanism...
16 KB (1,798 words) - 07:40, 1 February 2024
Saptarshi; Kapoor, Nitin (August 2021). "Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)". Diabetes Therapy. 12 (8):...
3 KB (97 words) - 12:15, 28 March 2024
metabolic hormones affecting blood glucose levels: catabolic hormones (such as glucagon, cortisol and catecholamines) which increase blood glucose; and one anabolic...
39 KB (4,033 words) - 08:44, 20 June 2024
dipeptidyl peptidase-4 (DPP-4) and are members of the glucagon peptide superfamily. Medications based on incretins are used in the treatment of type 2...
7 KB (885 words) - 12:53, 10 August 2024
Inotrope (redirect from Inotropic medication)
Phosphodiesterase inhibitors Enoximone Milrinone Amrinone Theophylline Glucagon Insulin Negative inotropic agents decrease myocardial contractility and...
9 KB (897 words) - 16:30, 12 July 2024
Pancreatitis (section Medications)
hypoglycemic agents are associated with pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated...
42 KB (4,131 words) - 23:01, 5 August 2024
Metformin (section Combination with other medications)
under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight...
149 KB (14,268 words) - 21:56, 31 July 2024
In contrast, the hormone glucagon is released by the pancreas as a response to lower than normal blood sugar levels. Glucagon initiates uptake of the stored...
22 KB (2,300 words) - 03:18, 13 August 2023
and Glucagon Signal the Need for Glycogen Breakdown". Biochemistry (5th ed.). New York: W.H. Freeman. ISBN 0-7167-3051-0. "Guideline 11.5: Medications in...
57 KB (6,552 words) - 19:02, 9 August 2024